Document Type

Article

Publication Date

11-2026

Identifier

DOI: 10.1038/s41598-026-65145-9; PMCID: PMC13736501

Abstract

Sexually transmitted infections (STIs) and unintended pregnancy remain critical global public health concerns affecting millions of women worldwide. To support the development of new multipurpose products offering non-hormonal contraception and activity against sexually transmitted pathogens, we evaluated copper sulfate, zinc lactate, L-(+)-lactic acid and their combinations as candidate pharmaceutical actives. We determined virucidal (HIV-1, HSV-2) and bactericidal (Neisseria gonorrhoeae, Chlamydia trachomatis) activity in vitro followed by in vivo efficacy testing against HSV-2, N. gonorrhoeae, and C. trachomatis in mice. In vitro, zinc lactate alone showed no inhibitory activity. In contrast, copper sulfate and lactic acid alone and in combination demonstrated activity against all tested pathogens. Furthermore, these combinations remained potent in the presence of vaginal and seminal fluids. Importantly, the actives - alone or combined - at concentrations that inhibited STI pathogens did not inhibit the growth of Lactobacillus crispatus, bacteria associated with an optimal vaginal microbiota. Further, copper sulfate and lactic acid alone and in combination inhibited vaginal HSV-2 and N. gonorrhoeae infection in mice. The combination conferred limited protection against vaginal C. trachomatis infection. These data demonstrate the advantages of combining copper sulfate and lactic acid and support further evaluation and development of this combination as a multipurpose prevention product.

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65145-9.

Journal Title

Sci Rep

Volume

16

First Page

36946

Last Page

36946

MeSH Keywords

Animals; Lactic Acid; Female; Mice; Copper Sulfate; Herpesvirus 2, Human; Chlamydia trachomatis; Neisseria gonorrhoeae; Humans; Anti-Infective Agents; Vagina; Sexually Transmitted Diseases

PubMed ID

43019115

Keywords

Diseases; Drug discovery; Medical research; Microbiology

Comments

Grants and funding

This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Publisher's Link: https://www.nature.com/articles/s41598-026-65145-9

Share

COinS